Skip to main content
Journey Medical Corporation (DERM)
NASDAQ: DERM · IEX Real-Time Price · USD
5.46
-0.05 (-0.91%)
At close: Jul 19, 2024, 4:00 PM
5.44
-0.02 (-0.37%)
Pre-market: Jul 20, 2024, 9:28 AM EDT

Journey Medical Revenue

Journey Medical had revenue of $80.00M in the twelve months ending March 31, 2024, with 27.82% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $13.03M with 6.69% year-over-year growth. In the year 2023, Journey Medical had annual revenue of $79.18M with 7.48% growth.

Revenue (ttm)
$80.00M
Revenue Growth
+27.82%
P/S Ratio
1.37
Revenue / Employee
$1,951,171
Employees
41
Market Cap
109.27M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202379.18M5.51M7.48%
Dec 31, 202273.67M10.54M16.69%
Dec 31, 202163.13M18.60M41.78%
Dec 31, 202044.53M9.61M27.52%
Dec 31, 201934.92M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Karyopharm Therapeutics 140.46M
CytomX Therapeutics 119.18M
Augmedix 48.70M
BrainsWay 34.26M
Elutia 28.99M
Adagene 18.11M
Armata Pharmaceuticals 4.70M
I-Mab 3.90M
Revenue Rankings

DERM News

More News